Market Cap 571.14M
Revenue (ttm) 91.28M
Net Income (ttm) -145.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -159.10%
Debt to Equity Ratio 0.00
Volume 322,600
Avg Vol 481,536
Day's Range N/A - N/A
Shares Out 28.00M
Stochastic %K 55%
Beta -0.20
Analysts Strong Sell
Price Target $49.55

Company Profile

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared co...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 362 6295
Address:
10770 Wateridge Circle, Suite 210, San Diego, United States
Mbuck17
Mbuck17 Aug. 28 at 10:08 AM
$ANAB Anaptys Announces Participation in September Investor Conferences SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: Cantor Global Healthcare Conference 2025, New York, NY Format – Fireside chat and one-on-one investor meetings Date and Time – Wednesday, Sept. 3, 2025 at 8:00am ET / 5:00am PT 2025 Wells Fargo Healthcare Conference, Boston, MA Format – Fireside chat and one-on-one investor meetings Date and Time – Thursday, Sept. 4, 2025 at 11:00am ET / 8:00am PT Stifel 2025 Virtual Immunology and Inflammation Forum, Virtual Format – Fireside chat and one-on-one investor meetings Date and Time – Tuesday, Sept. 16, 2025 at 12:00pm ET / 9:00am PT
0 · Reply
Sky360
Sky360 Aug. 27 at 8:44 PM
$ANAB 🚀
0 · Reply
Tradingonthepan
Tradingonthepan Aug. 27 at 1:36 PM
0 · Reply
Sky360
Sky360 Aug. 26 at 12:46 PM
$ANAB The stock has almost ZERO movement. What anticipated catalyst is driving optimism here? There appears to be very little interest.
2 · Reply
NitWitt
NitWitt Aug. 25 at 6:17 PM
$ANAB soon
1 · Reply
EntryTracker
EntryTracker Aug. 23 at 5:37 AM
$ANAB AnaptysBio is a clinical stage biotech with immuno-inflammatory pipeline and partnership dependencies
0 · Reply
Racerock98
Racerock98 Aug. 23 at 12:24 AM
$ANAB By far my worst investment, everything green today and this closes red. What is going on? Is it shorts? Do I need to take the loss? But all theses analysts have positive forecasts.
0 · Reply
Avocado_smash
Avocado_smash Aug. 16 at 6:10 PM
$TSAT $GRND $FLWS $TNGX $ANAB Over shorted on Float.
0 · Reply
hbwalk2
hbwalk2 Aug. 13 at 4:57 PM
$ACLX Head fake at open Someone in the know perhaps taking or adding to large position. $ANAB and $AXSM also looking strong
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 1:38 PM
UBS updates rating for AnaptysBio ( $ANAB ) to Neutral, target set at 18 → 20.
0 · Reply
Latest News on ANAB
Anaptys Announces Stock Repurchase Plan

Mar 24, 2025, 9:15 AM EDT - 5 months ago

Anaptys Announces Stock Repurchase Plan


Anaptys Announces Participation in March Investor Conferences

Feb 27, 2025, 4:15 PM EST - 6 months ago

Anaptys Announces Participation in March Investor Conferences


Actym Therapeutics Appoints Thomas Smart as CEO

Apr 24, 2024, 9:00 AM EDT - 1 year ago

Actym Therapeutics Appoints Thomas Smart as CEO

PGEN XOMA


Anaptys Named a BioSpace 2024 Best Places to Work Winner

Nov 7, 2023, 4:15 PM EST - 1 year ago

Anaptys Named a BioSpace 2024 Best Places to Work Winner


Mbuck17
Mbuck17 Aug. 28 at 10:08 AM
$ANAB Anaptys Announces Participation in September Investor Conferences SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: Cantor Global Healthcare Conference 2025, New York, NY Format – Fireside chat and one-on-one investor meetings Date and Time – Wednesday, Sept. 3, 2025 at 8:00am ET / 5:00am PT 2025 Wells Fargo Healthcare Conference, Boston, MA Format – Fireside chat and one-on-one investor meetings Date and Time – Thursday, Sept. 4, 2025 at 11:00am ET / 8:00am PT Stifel 2025 Virtual Immunology and Inflammation Forum, Virtual Format – Fireside chat and one-on-one investor meetings Date and Time – Tuesday, Sept. 16, 2025 at 12:00pm ET / 9:00am PT
0 · Reply
Sky360
Sky360 Aug. 27 at 8:44 PM
$ANAB 🚀
0 · Reply
Tradingonthepan
Tradingonthepan Aug. 27 at 1:36 PM
0 · Reply
Sky360
Sky360 Aug. 26 at 12:46 PM
$ANAB The stock has almost ZERO movement. What anticipated catalyst is driving optimism here? There appears to be very little interest.
2 · Reply
NitWitt
NitWitt Aug. 25 at 6:17 PM
$ANAB soon
1 · Reply
EntryTracker
EntryTracker Aug. 23 at 5:37 AM
$ANAB AnaptysBio is a clinical stage biotech with immuno-inflammatory pipeline and partnership dependencies
0 · Reply
Racerock98
Racerock98 Aug. 23 at 12:24 AM
$ANAB By far my worst investment, everything green today and this closes red. What is going on? Is it shorts? Do I need to take the loss? But all theses analysts have positive forecasts.
0 · Reply
Avocado_smash
Avocado_smash Aug. 16 at 6:10 PM
$TSAT $GRND $FLWS $TNGX $ANAB Over shorted on Float.
0 · Reply
hbwalk2
hbwalk2 Aug. 13 at 4:57 PM
$ACLX Head fake at open Someone in the know perhaps taking or adding to large position. $ANAB and $AXSM also looking strong
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 1:38 PM
UBS updates rating for AnaptysBio ( $ANAB ) to Neutral, target set at 18 → 20.
0 · Reply
Tradingonthepan
Tradingonthepan Aug. 12 at 10:30 AM
$ANAB always up pre market for a dump at open. Some fuckery
0 · Reply
Wrosebro
Wrosebro Aug. 12 at 1:01 AM
$ANAB The good news is this is about the 5Y average the bad news this is where the stock has averaged over 5 years...
0 · Reply
fortmort22
fortmort22 Aug. 8 at 2:17 PM
$ANAB regretting this thing but I do believe it will bounce needs to hold 19 or it could be a couple more dollar drop....
0 · Reply
Tradingonthepan
Tradingonthepan Aug. 8 at 12:54 PM
$ANAB green premarket. Ah wait a minute I’ve seen this one before
0 · Reply
Tradingonthepan
Tradingonthepan Aug. 8 at 10:22 AM
$ANAB Huffing copium here. Just a lil shake out. Everything’s fine. EVERYTHINGS FINE!
0 · Reply
fortmort22
fortmort22 Aug. 8 at 12:51 AM
$ANAB had paper hands sold 200 of my 500 shares at the end of the day. Can't just keep losing
0 · Reply
fortmort22
fortmort22 Aug. 7 at 7:22 PM
$ANAB robbed in broad
1 · Reply
Tradingonthepan
Tradingonthepan Aug. 7 at 7:04 PM
$ANAB wow. Well that’ll be that then..
0 · Reply
Sky360
Sky360 Aug. 7 at 6:27 PM
$ANAB Why does every time this stock gets a price target upgrade it drops like a rock?
1 · Reply
fortmort22
fortmort22 Aug. 7 at 4:52 PM
$ANAB what is happening here....
1 · Reply
Sky360
Sky360 Aug. 7 at 2:22 PM
$ANAB 🚀🚀🚀
0 · Reply
hen_lewis
hen_lewis Aug. 7 at 1:45 PM
$ANAB super high short %, earnings beat, insane analyst targets. Yet still red
1 · Reply